Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Supportive Care in Cancer
Erschienen in: Supportive Care in Cancer 9/2021

20.02.2021 | Original Article

A multidisciplinary working model for promoting return to work of cancer survivors

verfasst von: Miri Cohen, Dana Yagil, Rafael Carel

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite wide recognition of the necessity of an integrative maintenance and return to work (RTW) program for cancer survivors, no such program has been described in the literature.

Aims

To examine a working model of an integrative multidisciplinary health care approach for promoting RTW, using the Delphi method.

Methods

A working model for promoting cancer survivors’ RTW by oncology health professionals was subjected to two rounds of evaluation by an expert panel in accordance with the Delphi research method. Twenty-six international experts in oncology (social workers, nurses, psychologists, physicians, and cancer patients) participated in the first round and 16 participated in the second round.

Results

The mean score of the working model’s applicability was 6.07 (SD = 1.07, range = 1–7). The model outlines in detail an integrative approach for promotion of RTW according to two axes: the oncology health professionals’ role and the timeline axis featuring four stages of oncology treatment and follow-up.

Conclusions

Our proposed model addresses the need for an integrated program that may increase the rate of RTW and improve the quality of life of cancer survivors. The model should be subjected to further evaluation, especially its adaptability to different health systems in different countries.
Literatur
1.
de Boer AG, Taskila T, Ojajärvi A, Van Dijk FJ, Verbeek JH (2009) Cancer patients and unemployment: a meta-analysis and meta-regression. JAMA. 301(7):753–762CrossRefPubMed
2.
Mehnert A, de Boer A, Feuerstein M (2013) Employment challenges for cancer patients. Cancer. 119(11):2151–2159CrossRefPubMed
3.
de Boer AG, Torp S, Popa A, Horsboel T, Zadnik V, Rottenberg Y, Bardi E, Bultmann U, Sharp L (2020) Long-term work retention after treatment for cancer: a systematic review and meta-analysis. J Cancer Surviv 14(2):135–150CrossRefPubMedPubMedCentral
4.
Main DS, Nowels CT, Cavender TA, Etschmaier M, Steiner JF (2005) A qualitative study of work and work return in cancer patients. Psychooncology. 14(11):992–1004CrossRefPubMed
5.
6.
Yagil D, Goldblatt H, Cohen M (2019) Dyadic resources in the return to work of cancer patients: exploring supervisor–employee perspectives. Disabil Rehabil 41(18):2151–2158CrossRefPubMed
7.
Global Burden of Disease Cancer Collaboration (2018) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol 4(11):1553–1568CrossRef
8.
Seifart U, Schmielau J (2017) Return to work of cancer patients. Oncol Res Treat 40(12):760–763CrossRefPubMed
9.
Spelten ER, Sprangers MA, Verbeek JH (2002) Factors reported to influence the return to work of cancer patients: a literature review. Psychooncology. 11(2):124–131CrossRefPubMed
10.
Noeres D, Park-Simon TW, Grabow J, Sperlich S, Koch-Gießelmann H, Jaunzeme J, Geyer S (2013) Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population. Support Care Cancer 21(7):1901–1909CrossRefPubMed
11.
Rottenberg Y, Ratzon NZ, Jacobs JM, Cohen M, Peretz T, de Boer AG (2016) Unemployment risk and income change after testicular cancer diagnosis: a population-based study. Urol Oncol 34(1):5–27CrossRefPubMed
12.
Kessler RC, Greenberg PE, Mickelson KD, Meneades LM, Wang PS (2001) The effects of chronic medical conditions on work loss and work cutback. J Occup Environ Med 43(3):218–225CrossRefPubMed
13.
Carlsen K, Oksbjerg Dalton S, Frederiksen K, Diderichsen F, Johansen C (2008) Cancer and the risk for taking early retirement pension: a Danish cohort study. Scand J Public Health 36(2):117–125CrossRefPubMed
14.
De Rijk A, Amir Z, Cohen M, Furlan T, Godderis L, Knezevic B, Miglioretti M, Munir F, Popa AE, Sedlakova M, Torp S, Yagil D, Tamminga S, de Boer A (2020) The challenge of return to work in workers with cancer: employer priorities despite variation in social policies related to work and health. J Cancer Surviv 14:188–199CrossRefPubMed
15.
Bains M, Yarker J, Amir Z, Wynn P, Munir F (2012) Helping cancer patients return to work: what providers tell us about the challenges in assisting cancer patients with work questions. J Occup Rehabil 22(1):71–77CrossRefPubMed
16.
Bilodeau K, Tremblay D, Durand MJ (2018) Exploration of the contexts surrounding the implementation of an intervention supporting return-to-work after breast cancer in a primary care setting: starting point for an intervention development. J Multidiscip Healthc 11:75–83CrossRefPubMedPubMedCentral
17.
de Boer AG, Taskila TK, Tamminga SJ, Feuerstein M, Frings-Dresen MH, Verbeek JH (2015) Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev 9:CD007569
18.
Lamore K, Dubois T, Rothe U, Leonardi M, Girard I, Manuwald U, Nazarov S, Silvaggi F, Guastafierro E, Scaratti C, Breton T, Foucaud J (2019) Return to work interventions for cancer patients: a systematic review and a methodological critique. Int J Environ Res Public Health 16(8):1343CrossRefPubMedCentral
19.
Tamminga SJ, De Boer AGEM, Verbeek JHAM, Frings-Dresen MHW (2010) Return-to-work interventions integrated into cancer care: a systematic review. Occup Environ Med 67(9):639–648CrossRefPubMed
20.
Bilodeau K, Tremblay D, Durand MJ (2019) Gaps and delays in patientship care in the return-to-work pathway for patients of breast cancer—a qualitative study. Curr Oncol 26(3):e414–e417CrossRefPubMedPubMedCentral
21.
Månsson T, Lynøe N, Alexanderson K, Hinas E, Helgesson G, Friberg E (2019) Respectful encounters from healthcare professionals and return to work among 9032 long-term sick-listed due to cancer or due to other diagnoses: results from a Swedish population-based survey. Support Care Cancer 27(9):3555–3561CrossRefPubMedPubMedCentral
22.
Munir F, Kalawsky K, Wallis DJ, Donaldson-Feilder E (2013) Using intervention mapping to develop a work-related guidance tool for those affected by cancer. BMC Public Health 13(1):6CrossRefPubMedPubMedCentral
23.
Tamminga SJ, De Boer AG, Verbeek JH, Frings-Dresen MH (2012) Breast cancer patients’ views of factors that influence the return-to-work process—a qualitative study. Scand J Work Environ Health 38(2):144–154CrossRefPubMed
24.
Lamort-Bouché M, Peron J, Broc G, Kochan A, Jordan C, Letrilliart L, Fervers B, Fassier JB (2020) FASTRACS Group. Breast cancer specialists’ perspective on their role in their patients’ return to work: a qualitative study. Scand J Work Environ Health 46(2):177–187CrossRefPubMed
25.
McKay G, Knott V, Delfabbro P (2013) Return to work and cancer: the Australian experience. J Occup Rehabil 23(1):93–105CrossRefPubMed
26.
Morrison T, Thomas R, Guitard P (2015) Physicians’ perspectives on cancer patients’ work integration issues. Can Fam Physician 61(1):e36–e42PubMedPubMedCentral
27.
Verbeek JH, de Boer AG, van der Weide WE, Piirainen H, Anema JR, van Amstel RJ, Hartog F (2005) Patient satisfaction with occupational health physicians, development of a questionnaire. Occup Environ Med 62(2):119–123CrossRefPubMedPubMedCentral
28.
Alfano CM, Kent EE, Padgett LS, Grimes M, de Moor JS (2017) Making cancer rehabilitation services work for cancer patients: recommendations for research and practice to improve employment outcomes. PM&R 9(9S2):S398–S406CrossRef
29.
Nieuwenhuijsen K, Faber B, Verbeek JH, Neumeyer-Gromen A, Hees HL, Verhoeven AC, van der Feltz-Cornelis CM, Bültmann U (2014) Interventions to improve return to work in depressed people. Cochrane Database Syst Rev 12:CD006237
30.
Petersen KS, Momsen AH, Stapelfeldt CM, Olsen PR, Nielsen CV (2018) Return-to-work intervention during cancer treatment–the providers’ experiences. Eur J Cancer Care (Engl) 27(2):e12793CrossRef
31.
32.
Rosen B, Waitzberg R, Merkur S (2015) Israel: health system review. Health Syst Transit 17(6):1–212PubMed
33.
34.
de Rijk A, Amir Z, Cohen M, Furlan T, Godderis L, Knezevic B, Miglioretti M, Munir F, Popa AE, Sedlakova M, Torp S, Yagil D, Tamminga S, de Boer A (2020) The challenge of return to work in workers with cancer: employer priorities despite variation in social policies related to work and health. J Cancer Surviv. J Cancer Surviv 14:188–199CrossRefPubMed
35.
Greidanus MA, de Boer A, de Rijk AE, Frings-Dresen M, Tamminga SJ (2020) The MiLES intervention targeting employers to promote successful return to work of employees with cancer: design of a pilot randomised controlled trial. Trials. 21(1):363CrossRefPubMedPubMedCentral
36.
Yagil D, Eshed-Lavi N, Carel R, Cohen M (2018) Health care professionals’ perspective on return to work in cancer survivors. Psychooncology. 27:1206–1212CrossRefPubMed
37.
Fletcher AJ, Marchildon GP (2014) Using the Delphi method for qualitative, participatory action research in health leadership. Int J Qual Methods 13(1):1–18CrossRef
38.
Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14(12):1165–1174CrossRefPubMed
Metadaten
Titel
A multidisciplinary working model for promoting return to work of cancer survivors
verfasst von
Miri Cohen
Dana Yagil
Rafael Carel
Publikationsdatum
20.02.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06074-3

Weitere Artikel der Ausgabe 9/2021

Supportive Care in Cancer 9/2021 Zur Ausgabe

Original Article

Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors

Original Article

Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients

Original Article

Relationship between social support, physical symptoms, and depression in women with breast cancer and pain

Original Article

Parental views on communication between children and clinicians in pediatric oncology: a qualitative study

Original Article

Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study

Original Article

External validation of a model to identify cardiometabolic predictors of mortality in cancer survivors

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise